Instrument/analyser IVDs
Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Offentlig vurderingsrapport
(PAR)
29-05-2020
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Tilgjengelig fra:
Martin Flynn PTY LTD
Klasse:
Class 1
Produsert av:
DRG International Inc 841 Mountain Avenue, Springfield, NJ, 07081 United States Of America
Terapeutisk område:
CT943 - Instrument/analyser IVDs
Indikasjoner:
HYB-5252 -GMDN 56718/62413 - The DRG:HYBRiD-XL? was developed for the use in Laboratories, Institutions and Doctors Practices. The DRG:HYBRID-XL? is capable of processing a broad variety of Clinical Chemistry and immunoassay. The DRG:HYBRiD-XL? is a random-access analyzer intended for professional use and must only be used by trained personnel working in compliance with the precautions for use set out in this manual and good laboratory practice (GLP).
Autorisasjon status:
A
Autorisasjon dato:
2020-02-13
